NYSE
Bristol-Myers Squibb
$299.07
-2.31 (-0.77%)
Offline
Bull Bear Scale
BMY
48
score
Price action
299.07
−2.31 (−0.77%)1D
Market closed · Fri, Sep 18, 9:30 AM–4:00 PM ET
Click and drag to measure a move.Use two fingers to measure a move.
Reconnecting…
No messages yet
Say hi to everyone on Bull or Bear.
Live P&L tape
Real fills on BMY with cost-basis gains & losses
Offline
Your vote
One call per vote type per day — tap again to clear, or the other side to flip. Free accounts get 5 new calls/day across the app.
Sentiment-Desk
Crowd-Puls, konkurrierende Narrative, Split-News und gelabelte Street Takes — Bull und Bear abwägen, ohne die Seite zu verlassen.
Unsere Daten
48
Crowd and tape disagree — classic two-sided tape.
Desk-Signale
Crowd is cautious while tape lifts — trust the lean or the print?
48% Bull · 52% Bear
Contest-Hitze
Knife fight
Street-Mix
Street mixed
Vote-Fuel
Quiet room
Lebendes Narrativ
Zwei Briefings, die mit der Tagesstory rotieren — keine zusammengeführte Take.
Bullen sagen
Bulls are framing this as digestion after a run, not exhaustion: as long as the shelf holds, they’re adding, not exiting.
Updates with today’s narrative
Bären sagen
Bears want proof the bid is real. Until then, they’re treating green candles as exit liquidity.
Updates with today’s narrative
Split-Ansicht
Jede Spalte einzeln scrollen und Framing direkt vergleichen.
Bull-framed
BMY: constructive base, bulls keep the benefit of the doubt
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
Options flow: call interest rebuilding in BMY
The bull packet focuses on bid support and a still-open upside path if the shelf holds through the next session.
Street note: upside skew still favors Bristol-Myers Squibb
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
Bristol-Myers Squibb bulls lean on relative strength into the close
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
Why dip-buyers still want BMY on weakness
Call-side notes argue the crowd is early, not wrong — so long as price respects the recent base.
Bear-framed
Valuation overhang: the case against chasing Bristol-Myers Squibb
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
BMY bounce looks fragile — bears want lower highs
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Supply check: who is selling BMY into strength?
Bear briefs stress distribution tells and soft follow-through — green prints as liquidity, not confirmation.
Macro beta could swamp the BMY story this week
Risk notes flag stretched multiples and a tape that still needs a cleaner break to flip the lean.
Put buyers quietly rebuilding in BMY
Bear briefs stress distribution tells and soft follow-through — green prints as liquidity, not confirmation.
Cashtag-Chatter
Demo-Feed
Kurze Takes mit Bull/Bear-Label. Demo-Feed, bis ein Live-Social-Feed verbunden ist.
Adding a starter in $BMY — want follow-through, not hopium.
$BMY needs a real flush before I get interested long.
Relative strength in $BMY vs peers is the tell.
Crowded long narrative in $BMY. That’s the risk.
$BMY bids keep showing up. Not cute — constructive.
$BMY bids keep showing up. Not cute — constructive.
$BMY bounce = exit liquidity until proven otherwise.
Crowd is noisy but the tape in $BMY is cleaner than Twitter.
$BMY needs a real flush before I get interested long.
Crowd is noisy but the tape in $BMY is cleaner than Twitter.
Crowd is noisy but the tape in $BMY is cleaner than Twitter.
Crowd is noisy but the tape in $BMY is cleaner than Twitter.
Valuation + soft follow-through. $BMY still a fade for me.
Crowd is noisy but the tape in $BMY is cleaner than Twitter.
Mock profile for BMY used for swipe and chart demos.
Bull or Bear dient nur der Unterhaltung und Diskussion — keine Anlageberatung. Nutzungsbedingungen · Datenschutz · Safety. Marktpreise können simuliert oder verzögert sein.
